Dr Abd A Tahrani MD, MRCP (UK), MMedSci, CCT (Endocrinology and Diabetes), PhD, SCOPE (National Fellow)

Dr Abd A Tahrani

Institute of Metabolism and Systems Research
NIHR Clinician Scientist

Contact details

Address
Institute of Metabolism and Systems Research
College of Medical and Dental Sciences
University of Birmingham
Edgbaston
Birmingham
B15 2TT
UK

Abd Tahrani is a National Institute for Health Research (NIHR) Clinician Scientist at the University of Birmingham (UoB), and a Honorary Consultant Endocrinologist and the lead for weight management research and diabetic neuropathy services at Heart of England NHS Foundation Trust, Birmingham, UK.

He leads a multi-disciplinary research group that include scientists, clinicians and allied health-care professionals. The aims of this research group are to:

  • examine the impact of sleep-related disorders (including obstructive apnoea) on metabolic health, diabetes and obesity
  • improve our understanding of the pathogenesis of diabetes-related microvascular complications (peripheral neuropathy, autonomic neuropathy, nephropathy, retinopathy) and to identify new treatment targets and effective screening strategies.
  • improve our understanding of the pathogenesis of foot ulceration in diabetes and develop new treatments
  • explore the pharmacological and non-pharmacological options to treat and manage patients with obesity (including the long term outcomes of bariatric surgery)
  • develop new treatments for type 2 diabetes

 Dr. Tahrani has published over 80 peer reviewed articles and book chapters and in excess of 100 abstracts. He is regularly invited to speak in many of the leading national and international conferences in USA, Europe and Asia.

 Dr. Tahrani has won several national and international awards including SCOPE National Fellow from the World Obesity Federation in 2014, The Diabetes UK best primary care poster award 2014, NIHR Clinician Scientist award in 2013, the American Academy of Sleep Medicine Sleep Disordered Breathing investigator of the year award in 2013, The Sanofi Aventis Clinical Excellence Award in 2009, the Society for Endocrinology presentations award 2009, and a NIHR personal research training fellowship in 2008, in addition to several regional and local awards. He was also nominated to the Nick Hales young investigator award by Diabetes UK and he was recently elected as a member of  Neurodiab (The diabetic neuropathy group of the EASD).

 He previously served on the clinical committee of The Society for Endocrinology and is currently the diabetes and metabolism section editor for BMC Endocrine disorders and an editorial advisor to BMC Obesity. He serves on the editorial boards of several journals and was the editorial consultant for the type 1 diabetes module of the American College of Physicians.

 Dr Tahrani is a regular reviewer of grants submitted to several NIHR streams and the Hong Kong research council amongst others and a regular peer reviewer to several leading journals in the fields of medicine, endocrinology, diabetes and obesity

 Dr. Tahrani is an examiner at the Royal College of Physicians and served as an expert advisor to NICE.

Qualifications

  • SCOPE National Fellow 2014
  • PhD in sleep, diabetes and microvascular complications 2013
  • CCT (Diabetes and Endocrinology) 2012
  • MMedSci 2008
  • MRCP (UK) 2003
  • MD 1998

Biography

Abd Tahrani is a National Institute for Health Research (NIHR) Clinician Scientist at the University of Birmingham (UoB), and a Honorary Consultant Endocrinologist at Heart of England and the University Hospitals of Birmingham NHS Foundation Trusts. He is also the lead for weight management research and diabetic neuropathy services at Birmingham Heartlands Hospital.

Following his MD in 1998 from Aleppo University in Syria he continued post graduate training in the UK and obtained MRCP (UK) in 2003, Master of Medical Sciences (MMedSci) in 2008, CCT in Diabetes & Endocrinology in 2012, PhD in 2013, SCOPE National Fellowship in 2014 and FRCP (London) in 2017.

Dr Tahrani’s group at the UoB has the following research themes: obesity management and treatment (including bariatric surgery), the metabolic consequences of sleep-related disorders, the pathogenesis of diabetes-related microvascular complications (particularly neuropathy and nephropathy), and the pharmacology of type 2 diabetes and obesity.

Dr. Tahrani has published over 120 peer reviewed articles and book chapters and more than 150 abstracts. He was invited to speak in many of the leading national and international conferences in the fields of Obesity, Diabetes, Endocrinology, and Sleep medicine such as Endo, ADA, SLEEP, NeuroDiab, YDEF, the BES, The World Obesity Federation SCOPE school, EASDec, the Greek Obesity Society, CPD activities for the RCP (London) and the RCSP (Glasgow), and other conferences in Asia and Europe.

He has won several awards including SCOPE National Fellowship from the World Obesity Federation, The Diabetes UK best primary care poster award, NIHR Clinician Scientist award, the American Academy of Sleep Medicine Sleep Disordered Breathing investigator of the year award, The Sanofi Aventis Clinical Excellence Award, the Society for endocrinology presentations award, and a NIHR personal fellowship in 2008 amongst others. He was also nominated to the Nick Hales young investigator award by Diabetes UK.

Dr. Tahrani is an elected member of the Neurodiab group of the EASD, a trustee of the ASO (UK), a panel member of the NIHR RfPB and an Expert advisor to the Medical Technology Advisory Committee of NICE.  He is the Midlands region co-lead for the ASO (UK). He was also a member of the Clinical Committee of the SfE and a member of the Speciality Question writing group for the MRCP.

He is currently the diabetes and metabolism section editor for BMC Endocrine disorders, an editorial advisor to BMC Obesity and the Editor-in-Chief for European Endocrinology.  He was the editorial consultant for the type 1 diabetes module for the American College of Physicians. Dr Tahrani is a regular grant reviewer to all the NIHR grant streams, the Hong Kong research council, Diabetes UK, The Novo Nordisk Research Foundation, the MRC, the BBSRC, and the New Zealand research council amongst others. Dr Tahrani is also a regular peer reviewer to several leading journals including the Lancet, Lancet Diabetes & Endocrinology, Annals of internal Medicine, BMJ, JACC, Diabetes care, and Diabetologia amongst others.

Postgraduate supervision

  • Supervisor for two MD students, two PhD students and six Masters students.
  • Mentor for four postgraduate students to obtain research training fellowships.
  • Postgraduate students (clinicians, scientists or allied health-care professionals) ,  interested in pursuing an academic career or aim to obtain and postgraduate qualifications in one of Abd's research interest areas are welcome to contact him directly.

Research

Research aims:

  • To examine the impact of sleep-related disorders (including obstructive apnoea) on metabolic health, diabetes and obesity
  • To improve our understanding of the pathogenesis of diabetes-related microvascular complications (peripheral neuropathy, autonomic neuropathy, nephropathy, retinopathy) and to identify new treatment targets and effective screening strategies.
  • To improve our understanding of the pathogenesis of foot ulceration in diabetes and develop new treatments
  • To explore the pharmacological and non-pharmacological options to treat and manage patients with obesity (including the long term outcomes of bariatric surgery)
  • To develop new treatments for type 2 diabetes

http://www.birmingham.ac.uk/research/activity/metabolism-systems/research/sleep-metabolism-obesity-and-diabetic-complication/index.aspx

Other activities

  • Lead for Weight Management Research and Diabetic Neuropathy Services at Birmingham Heartlands Hospital
  • The Diabetes and Metabolism Section Editor for BMC Endocrine Disorders
  • An Editorial Advisor for BMC Obesity
  • An editorial board member of Review of Diabetic Studies, clinical medicine case reports medical journal, the World Journal of Diabetes, Biomed Research International and the Journal of Translational Internal Medicine
  • Grant reviewer for national and international research funding organisations including the Hong Kong Medical Research Council, and National Institute for Health research (UK) including Health Technology Assessments (HTA), Research for Patient Benefit (RfPB), Efficacy and Mechanism Evaluation (EME) and Health Service Delivery evaluations
  • Regular peer reviewer to several leading journal including the Lancet, Lancet Diabetes & Endocrinology, Annals of Internal Medicine, Journal of American College of Cardiology, BMJ, Canadian Medical Association Journal, Annals of Medicine, Thorax, Diabetes Care, Diabetologia, Diabetic Medicine, Clinical Endocrinology, British Journal of General Practice, BMC Endocrine Disorders, Thyroid, Endocrine Practice, Journal of the American Society of Nephrology, Drug and Therapeutic Bulletin, Ophthalmology, American Journal of Kidney Disease disorders, Diabetes Research and Clinical Practice, Cardiovascular Diabetologia, BMJ Open Diabetes Research, Journal of Clinical Sleep Medicine,  Emirates Medical Journal, BMJ Open, Diabetes and Vascular Disease Research, PLOS One, PLOS Medicine, and Review of Diabetic Studies amongst others.
  • MRCP examiner
  • Editorial consultant for the Type 1 diabetes module provided by the American College of Physicians
  • Expert advisor to the National Institute for Health Care Excellence (NICE) in England
  • Member of the Clinical Committee of the Society of Endocrinology and a member of the West Midlands Postgraduate Medicine Board in the West Midlands Deanery
  • Trustee for the Association for the Study of Obesity

Publications

Expertise

Obesity, sleep apnoea, diabetes